Answers are grounded in this paper and cite their sources.
Metabolite repair is a necessary, yet understudied concept in metabolic biochemistry that strives to characterize non-canonical metabolites formed by enzymatic side activities or spontaneous reactions and the enzymes that are responsible for converting these often-toxic molecules to useful substrates. Citrate lyase beta-like protein (CLYBL) is a ubiquitously expressed, mammalian enzyme that has recently garnered attention for its role in the degradation itaconate, a highly localized metabolite that activated macrophages produce to defend against pathogens. The host cell activates itaconate to itaconyl-CoA which is then converted to citramalyl-CoA to be finally cleaved into acetyl-CoA and pyruvate by CLYBL. A loss-of-function single nucleotide polymorphism in the CLYBL gene is present in 2.7% of all human chromosomes and has been associated with low levels of circulating vitamin B12. Itaconyl-CoA is a suicide inhibitor of the B12-dependent enzyme methylmalonyl-CoA mutase (MCM); however, the highly inducible and locally confined production of itaconate makes it unlikely to be the main cause of reduced circulating B12 levels in CLYBL deficient people. We have uncovered another main physiological function of CLYBL, namely, to act as a metabolite repair enzyme to degrade a more ubiquitously formed acyl-CoA ester by promiscuity of TCA cycle enzymes that we identified using CLYBL deficient cell lines. People who harbor null CLYBL alleles cannot eliminate this damaging metabolite which we identified is a potent inhibitor of MCM, consequently depleting adenosylcobalamin. Significantly, this work establishes a molecular culprit of B12 deficiency that can form in all cell types, providing the groundwork to examine the effects of CLYBL deficiency on human health.
No takes yet. Share an insight, caveat, or question.
Griffith et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: